Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - Genes & development, 2016 - genesdev.cshlp.org
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
[PDF][PDF] Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - 2016 - core.ac.uk
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
Mechanisms of metabolic dysfunction in cancer-associated cachexia.
M Petruzzelli, EF Wagner - Genes & Development, 2016 - europepmc.org
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
[PDF][PDF] Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - 2016 - pdfs.semanticscholar.org
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
[PDF][PDF] Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - 2016 - cyberleninka.org
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
[HTML][HTML] Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - Genes & Development, 2016 - ncbi.nlm.nih.gov
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - Genes & Development, 2016 - cir.nii.ac.jp
抄録< jats: p> Metabolic dysfunction contributes to the clinical deterioration observed in
advanced cancer patients and is characterized by weight loss, skeletal muscle wasting, and …
advanced cancer patients and is characterized by weight loss, skeletal muscle wasting, and …
Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - 2016 - lareferencia.info
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
Mechanisms of metabolic dysfunction in cancer-associated cachexia
M Petruzzelli, EF Wagner - Genes & development, 2016 - pubmed.ncbi.nlm.nih.gov
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
Mechanisms of metabolic dysfunction in cancer-associated cachexia.
M Petruzzelli, EF Wagner - 2016 - repository.cam.ac.uk
Metabolic dysfunction contributes to the clinical deterioration observed in advanced cancer
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …
patients and is characterized by weight loss, skeletal muscle wasting, and atrophy of the …